HomeIDIA • SWX
Idorsia Ltd
CHF 0.74
Jan 15, 6:10:03 AM GMT+1 · CHF · SWX · Disclaimer
StockCH listed security
Previous close
CHF 0.72
Day range
CHF 0.72 - CHF 0.83
Year range
CHF 0.61 - CHF 3.70
Market cap
140.22M CHF
Avg Volume
1.71M
P/E ratio
-
Dividend yield
-
Primary exchange
SWX
In the news
Financials
Income Statement
Revenue
Net income
(CHF)Sep 2024Y/Y change
Revenue
26.20M-67.21%
Operating expense
63.99M-6.32%
Net income
-101.04M-145.10%
Net profit margin
-385.61-237.55%
Earnings per share
EBITDA
-83.92M-83.27%
Effective tax rate
-0.17%
Total assets
Total liabilities
(CHF)Sep 2024Y/Y change
Cash and short-term investments
103.15M-61.24%
Total assets
512.84M-21.48%
Total liabilities
1.64B10.43%
Total equity
-1.13B
Shares outstanding
188.31M
Price to book
-0.12
Return on assets
-37.84%
Return on capital
-125.83%
Net change in cash
(CHF)Sep 2024Y/Y change
Net income
-101.04M-145.10%
Cash from operations
-143.71M-88.55%
Cash from investing
-1.23M-100.46%
Cash from financing
0.00100.00%
Net change in cash
-92.14M-190.50%
Free cash flow
-83.97M-2,363.30%
About
Idorsia is a Swiss pharmaceutical research company in Allschwil, near Basel, Switzerland. Wikipedia
Founded
2017
Employees
938
Search
Clear search
Close search
Google apps
Main menu